NEW DELHI: Even when the chances of re-infection with Covid-19 are low, vaccination against Covid-19 is likely to protect people from severe symptoms if a new infection occurs after the immunity of the vaccine expires, says AIIMS director Dr. Randeep Guleria. Dr. Guleria said that long-term studies will be needed …
Read More »
The COVID-19 candidate vaccine ‘Covaxin’, in phase 3 clinical trials, is being developed by Bharat Biotech Calcutta: West Bengal Governor Jagdeep Dhankhar today inaugurated the launch of Covaxin’s phase 3 regulatory trial at ICMR-NICED in Kolkata, praising the country’s leadership in “effectively addressing” the COVID-19 pandemic. Dhankhar said the NICED …
Read More »
The five healthy volunteers, who received an injection of the Covid-19 vaccine from Bharat Biotech International Limited at Sola Civil Hospital in Ahmedabad of Gujarat, have not complained of any health problems so far, a senior doctor said on Friday. During the phase 3 clinical trials of Covaxin, the first …
Read More »
NEW DELHI: As the national expert group on the Covid-19 vaccine strengthens plans for the procurement and distribution of injections, the Center is betting on the five candidate vaccines currently in clinical trials in India. Candidates include three that are in advanced stages of trials in India: the Oxford-AstraZeneca candidate …
Read More »